Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shofu Inc. (7979.T)
JPY2,189.00
+66.00 (+3.11%)
JP JPX Healthcare Medical - Instruments & Supplies
Address
11 Kamitakamatsu-cho 605-0983
Kyoto, JP
Kyoto, JP
CEO
Tetsuo Takami
Website
shofu.co.jp
IPO
2005-09-29
ISIN JP3363600002
Description
Headquartered in Kyoto, Japan, Shofu Inc. is a long-standing global supplier of diverse dental materials and specialized equipment, having been established in 1922. The company offers an extensive product range, encompassing everything from artificial teeth, dental porcelains, and various abrasives and polishers to dental alloys, cements, restorative substances, waxes, investment materials, and orthodontic devices, alongside preventative infection control solutions. The organization adopted its current name, Shofu Inc., in 1983, having previously operated as Shofu Dental Mfg. Co., Ltd.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY2,189.00
+66.00 (+3.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
126.1K
Beta
0.15
Float Shares
22.71M
Free Float %
63.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.06% | +4.74% | +0.41% | -4.23% | -7.12% | -5.38% | -19.00% | +61.24% | +84.07% | +144.08% | +205.59% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2,189.00
DCF (Unlevered)
1,524.28
-30.4%
DCF (Levered)
1,248.44
-43.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.28
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+3.4% Q1'26: +10.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+13.1% Q1'26: +76.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+3.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+13.1% Q1'26: +13.1% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+10.1% ★ Q1'26: +13.3% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.00× ★ Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 1 Rev. Ana. 2 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
19.69B
est: 20.00B (-1.6%)
|
22.98B
est: 21.00B (+9.4%)
|
24.92B
est: 25.50B (-2.3%)
|
26.11B
est: 26.00B (+0.4%)
|
24.68B
est: 24.70B (-0.1%)
|
28.14B
est: 27.75B (+1.4%)
|
31.68B
est: 31.39B (+0.9%)
|
35.08B
est: 36.27B (-3.3%)
|
38.70B
est: 39.06B (-0.9%)
|
39.59B
39.30B – 39.97B
+1.4% YoY
|
42.11B
41.75B – 42.43B
+6.4% YoY
|
45.34B
44.60B – 46.00B
+7.7% YoY
|
49.04B
48.63B – 49.41B
+8.2% YoY
|
52.80B
52.36B – 53.20B
+7.7% YoY
|
| EBITDA |
1.94B
est: 3.34B (-41.8%)
|
2.63B
est: 3.50B (-24.9%)
|
2.71B
est: 4.26B (-36.4%)
|
2.17B
est: 4.34B (-49.9%)
|
3.26B
est: 4.12B (-21.0%)
|
4.52B
est: 4.63B (-2.3%)
|
5.40B
est: 5.24B (+3.1%)
|
6.47B
est: 6.15B (+5.3%)
|
7.23B
est: 6.62B (+9.2%)
|
6.71B
6.66B – 6.77B
+1.4% YoY
|
7.14B
7.08B – 7.19B
+6.4% YoY
|
7.68B
7.56B – 7.80B
+7.7% YoY
|
8.31B
8.24B – 8.38B
+8.2% YoY
|
8.95B
8.87B – 9.02B
+7.7% YoY
|
| EBIT |
1.16B
est: 2.69B (-56.8%)
|
1.57B
est: 2.82B (-44.4%)
|
1.72B
est: 3.43B (-49.9%)
|
1.20B
est: 3.50B (-65.8%)
|
2.30B
est: 3.32B (-30.7%)
|
3.62B
est: 3.73B (-2.9%)
|
4.43B
est: 4.22B (+4.9%)
|
5.31B
est: 5.17B (+2.5%)
|
6.17B
est: 5.57B (+10.8%)
|
5.65B
5.61B – 5.70B
+1.4% YoY
|
6.01B
5.96B – 6.05B
+6.4% YoY
|
6.47B
6.36B – 6.56B
+7.7% YoY
|
7.00B
6.94B – 7.05B
+8.2% YoY
|
7.53B
7.47B – 7.59B
+7.7% YoY
|
| Net Income |
581.00M
est: 1.11B (-47.5%)
|
789.00M
est: 1.22B (-35.2%)
|
1.20B
est: 1.29B (-6.8%)
|
704.00M
est: 1.62B (-56.6%)
|
1.67B
est: 1.39B (+20.8%)
|
2.55B
est: 2.51B (+1.6%)
|
3.14B
est: 3.11B (+0.9%)
|
3.66B
est: 4.09B (-10.6%)
|
4.32B
est: 4.59B (-5.9%)
|
4.42B
4.14B – 4.71B
-3.6% YoY
|
4.81B
4.66B – 4.97B
+8.8% YoY
|
5.41B
5.04B – 6.02B
+12.3% YoY
|
5.45B
5.40B – 5.51B
+0.7% YoY
|
5.93B
5.86B – 5.99B
+8.9% YoY
|
| SGA |
8.52B
est: 8.27B (+3.0%)
|
10.18B
est: 8.69B (+17.2%)
|
11.14B
est: 10.55B (+5.6%)
|
10.94B
est: 10.75B (+1.7%)
|
9.73B
est: 10.22B (-4.7%)
|
11.21B
est: 11.48B (-2.3%)
|
13.03B
est: 12.98B (+0.4%)
|
14.36B
est: 15.50B (-7.4%)
|
17.60B
est: 16.69B (+5.4%)
|
16.92B
16.79B – 17.08B
+1.4% YoY
|
17.99B
17.84B – 18.13B
+6.4% YoY
|
19.37B
19.06B – 19.66B
+7.7% YoY
|
20.96B
20.78B – 21.12B
+8.2% YoY
|
22.57B
22.38B – 22.74B
+7.7% YoY
|
| EPS |
36.45
est: 31.05 (+17.4%)
|
49.43
est: 34.15 (+44.7%)
|
75.53
est: 36.15 (+108.9%)
|
44.19
est: 45.45 (-2.8%)
|
48.15
est: 38.85 (+23.9%)
|
71.61
est: 70.28 (+1.9%)
|
88.05
est: 87.11 (+1.1%)
|
103.09
est: 115.24 (-10.5%)
|
121.50
est: 128.67 (-5.6%)
|
123.87
115.90 – 132.10
-3.7% YoY
|
134.90
130.47 – 139.33
+8.9% YoY
|
151.93
141.10 – 168.60
+12.6% YoY
|
152.95
151.40 – 154.50
+0.7% YoY
|
166.10
164.29 – 167.74
+8.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.00B
OE per share TTM
28.06
Owner's Yield
1.63%
Maintenance CapEx ratio
26.53%
Maint CapEx / Avg PPE
29.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 32 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.05% | 187.2K | 0.58% |
| 2 | WisdomTree Japan Hedged Equity Fund DXJ | 0.02% | 1.60M | 0.48% |
| 3 | WisdomTree Japan Equity UCITS ETF - USD Acc DXJZ.L | 0.02% | 173.5K | 0.40% |
| 4 | WisdomTree Japan Equity UCITS ETF - USD Hedged Acc DXJA.L | 0.02% | 173.5K | 0.48% |
| 5 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.02% | 214.1K | 0.45% |
| 6 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.02% | 173.5K | 0.48% |
| 7 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.02% | 232.0K | 0.45% |
| 8 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.02% | 197.6K | 0.45% |
| 9 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 712.3K | 0.06% |
| 10 | Dimensional - International Small Cap ETF DFIS | 0.01% | 388.1K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
3.82M
Shares Outstanding
35.59M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fumitaka Yamazaki | Senior Managing Executive Officer of Corporate Planning & Director | — | male |
| Hiroyoshi Miyake | Executive Officer & Head of Comprehensive Planning Department | — | — |
| Kazuhiko Murakami | Executive Vice President of Sales and International | — | male |
| Ryuichi Yoshimoto | Managing Executive Officer and In charge of Research and Development, Technology & Marketing | — | — |
| Shinya Teramoto | Managing Executive Officer of Personnel | — | — |
| Shuji Sonoi | Managing Executive Officer & GM of Production Department and Director | — | male |
| Takahiro Umeda | Senior Managing Executive Officer of Finance, IT & Nail Bus and Representative Director | — | male |
| Takashi Wakayama | Executive Officer & President and CEO of Smart Dentistry Solutions Inc. | — | — |
| Tetsuo Takami | Representative Director, President & Chief Executive Officer | — | male |
| Tomonori Matsunaga | Executive Officer & Marketing Director | — | — |
| Toshiyuki Nakatsuka | Senior Executive Officer | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7979.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
